Peter Hillemanns
Papers
7
Total Citations
224
H-Index
7
About
Peter Hillemanns is a distinguished gynecologic oncologist whose research has significantly advanced understanding of two critical areas: borderline ovarian tumors (BOT) and surgical treatment strategies for early cervical cancer. As a key contributor to the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, Hillemanns helped establish foundational insights into how age and surgical staging influence outcomes in borderline ovarian tumors, with his seminal 2014 paper accumulating 75 citations and demonstrating that patient age meaningfully shapes clinical presentation and prognosis. His work on cervical cancer surgery has been equally impactful, addressing one of modern gynecologic oncology's most pressing controversies: whether minimally invasive radical hysterectomy compromises oncological safety compared to open surgery. Through rigorous systematic reviews, meta-analyses, and innovative proof-of-principle studies — including pioneering use of ICG-stained cervical secretion to model tumor cell dissemination during laparoscopic procedures — Hillemanns has provided critical evidence informing surgical decision-making. His contributions to expert commentary on the landmark LACC trial further underscore his standing as an influential voice shaping international guidelines and clinical practice in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7